Iovance Biotherapeutics: Q2 Earnings Snapshot
SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Tuesday reported a loss of $106.5 million in its second quarter.
On a per-share basis, the San Carlos, California-based company said it had a loss of 47 cents.
The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 81 cents per share.
The biotechnology company posted revenue of $238,000 in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA
